Gene Symbol | Gene ID | Gene Info |
---|---|---|
SOX17
|
ENSG00000164736.5 | SRY-box transcription factor 17 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_55366717_55366868 | SOX17 | 3703 | 0.302189 | -0.81 | 8.5e-03 | Click! |
chr8_55379558_55379709 | SOX17 | 9138 | 0.261717 | -0.74 | 2.2e-02 | Click! |
chr8_55367558_55367715 | SOX17 | 2859 | 0.336887 | -0.66 | 5.3e-02 | Click! |
chr8_55366934_55367085 | SOX17 | 3486 | 0.309113 | -0.62 | 7.7e-02 | Click! |
chr8_55366358_55366509 | SOX17 | 4062 | 0.292759 | -0.62 | 7.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_79575534_79575744 | 0.39 |
ENSG00000238816 |
. |
14385 |
0.21 |
chr18_46270227_46270648 | 0.36 |
RP11-426J5.2 |
|
55647 |
0.13 |
chr11_67141426_67142374 | 0.35 |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
252 |
0.81 |
chr20_9239531_9239912 | 0.35 |
PLCB4 |
phospholipase C, beta 4 |
41684 |
0.21 |
chr12_118124324_118124475 | 0.35 |
KSR2 |
kinase suppressor of ras 2 |
12203 |
0.3 |
chr13_76225766_76225917 | 0.34 |
LMO7 |
LIM domain 7 |
15382 |
0.17 |
chr1_221099074_221099301 | 0.33 |
HLX |
H2.0-like homeobox |
44603 |
0.15 |
chr11_34449252_34449782 | 0.32 |
CAT |
catalase |
10955 |
0.23 |
chr4_114305053_114305337 | 0.31 |
ANK2 |
ankyrin 2, neuronal |
10680 |
0.22 |
chr5_90603533_90603789 | 0.31 |
ENSG00000199643 |
. |
37117 |
0.18 |
chr11_73024899_73025487 | 0.31 |
ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
2583 |
0.2 |
chr15_67055010_67055873 | 0.30 |
SMAD6 |
SMAD family member 6 |
51406 |
0.15 |
chr9_91390340_91390723 | 0.30 |
ENSG00000265873 |
. |
29711 |
0.24 |
chr7_26893246_26893503 | 0.29 |
SKAP2 |
src kinase associated phosphoprotein 2 |
3865 |
0.32 |
chr8_95983279_95983772 | 0.29 |
NDUFAF6 |
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 |
9636 |
0.15 |
chr10_706571_706722 | 0.29 |
RP11-809C18.5 |
|
2852 |
0.21 |
chr1_185368997_185369148 | 0.29 |
ENSG00000252407 |
. |
34304 |
0.19 |
chr10_28004089_28004350 | 0.27 |
MKX |
mohawk homeobox |
28255 |
0.18 |
chr10_80022765_80022916 | 0.27 |
ENSG00000201393 |
. |
104424 |
0.08 |
chr10_78318665_78318816 | 0.26 |
RP11-325D15.2 |
|
2012 |
0.47 |
chr6_82886298_82886449 | 0.26 |
ENSG00000223044 |
. |
33784 |
0.21 |
chr7_80264220_80264371 | 0.26 |
CD36 |
CD36 molecule (thrombospondin receptor) |
3665 |
0.37 |
chr2_238318033_238318184 | 0.26 |
COL6A3 |
collagen, type VI, alpha 3 |
4683 |
0.23 |
chr13_28534615_28535489 | 0.26 |
CDX2 |
caudal type homeobox 2 |
10224 |
0.14 |
chr5_158173853_158174004 | 0.26 |
CTD-2363C16.1 |
|
236086 |
0.02 |
chr6_16391457_16391608 | 0.26 |
ENSG00000265642 |
. |
37222 |
0.21 |
chr11_118475244_118475483 | 0.25 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
1792 |
0.23 |
chr16_75278250_75278858 | 0.25 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
1954 |
0.25 |
chr7_77079843_77080131 | 0.25 |
ENSG00000238453 |
. |
26882 |
0.19 |
chr10_90724518_90724791 | 0.25 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
12124 |
0.15 |
chr3_29555706_29555931 | 0.24 |
RBMS3-AS2 |
RBMS3 antisense RNA 2 |
102728 |
0.08 |
chr12_20658278_20658429 | 0.24 |
RP11-284H19.1 |
|
135157 |
0.05 |
chr1_68048532_68048683 | 0.24 |
ENSG00000207504 |
. |
41797 |
0.16 |
chr5_93581719_93582069 | 0.24 |
FAM172A |
family with sequence similarity 172, member A |
134513 |
0.05 |
chr12_15950766_15950967 | 0.24 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
8356 |
0.28 |
chr6_116733337_116733739 | 0.24 |
DSE |
dermatan sulfate epimerase |
41428 |
0.1 |
chr10_4720032_4720183 | 0.24 |
AKR1E2 |
aldo-keto reductase family 1, member E2 |
108714 |
0.07 |
chr2_159365928_159366227 | 0.23 |
ENSG00000251721 |
. |
24635 |
0.18 |
chr6_134299599_134299750 | 0.23 |
TBPL1 |
TBP-like 1 |
25312 |
0.21 |
chr7_18794771_18794922 | 0.23 |
ENSG00000222164 |
. |
53056 |
0.17 |
chr3_177624604_177624755 | 0.23 |
ENSG00000199858 |
. |
100888 |
0.09 |
chr4_88727397_88727610 | 0.23 |
IBSP |
integrin-binding sialoprotein |
6770 |
0.18 |
chr5_53949820_53950094 | 0.23 |
SNX18 |
sorting nexin 18 |
136364 |
0.05 |
chr7_80414599_80414988 | 0.23 |
CD36 |
CD36 molecule (thrombospondin receptor) |
112101 |
0.07 |
chr1_235053615_235054079 | 0.23 |
ENSG00000239690 |
. |
13914 |
0.26 |
chr1_94761220_94761475 | 0.23 |
ARHGAP29 |
Rho GTPase activating protein 29 |
58158 |
0.14 |
chr4_19776674_19776825 | 0.23 |
SLIT2 |
slit homolog 2 (Drosophila) |
478134 |
0.01 |
chr12_63292090_63292337 | 0.23 |
PPM1H |
protein phosphatase, Mg2+/Mn2+ dependent, 1H |
36604 |
0.16 |
chr2_191706793_191706944 | 0.22 |
GLS |
glutaminase |
38685 |
0.16 |
chr9_114721568_114721719 | 0.22 |
ENSG00000266315 |
. |
27263 |
0.16 |
chr7_80415975_80416126 | 0.22 |
CD36 |
CD36 molecule (thrombospondin receptor) |
113358 |
0.07 |
chr19_33885604_33886026 | 0.22 |
CEBPG |
CCAAT/enhancer binding protein (C/EBP), gamma |
20597 |
0.19 |
chr17_36607297_36607925 | 0.22 |
ENSG00000260833 |
. |
321 |
0.87 |
chr15_39438573_39438724 | 0.22 |
RP11-624L4.1 |
|
27734 |
0.25 |
chr12_102288439_102288933 | 0.22 |
DRAM1 |
DNA-damage regulated autophagy modulator 1 |
13406 |
0.14 |
chr8_48435057_48435320 | 0.22 |
RP11-697N18.4 |
|
4771 |
0.31 |
chr4_129388350_129388501 | 0.22 |
PGRMC2 |
progesterone receptor membrane component 2 |
178441 |
0.03 |
chr2_69480804_69480955 | 0.22 |
ENSG00000199460 |
. |
70870 |
0.09 |
chr2_173995015_173995166 | 0.22 |
MLTK |
Mitogen-activated protein kinase kinase kinase MLT |
39743 |
0.17 |
chr12_120130068_120130348 | 0.22 |
RP1-127H14.3 |
Uncharacterized protein |
7365 |
0.17 |
chr2_102686423_102686780 | 0.22 |
IL1R1 |
interleukin 1 receptor, type I |
235 |
0.95 |
chr9_112942282_112942517 | 0.22 |
C9orf152 |
chromosome 9 open reading frame 152 |
28070 |
0.2 |
chr5_67667888_67668039 | 0.21 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
79567 |
0.11 |
chr2_213462726_213462977 | 0.21 |
ERBB4 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
59286 |
0.16 |
chr8_22562900_22563666 | 0.21 |
EGR3 |
early growth response 3 |
12468 |
0.13 |
chr4_41015470_41015621 | 0.21 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
857 |
0.64 |
chr15_39997484_39997635 | 0.21 |
RP11-37C7.3 |
|
77213 |
0.08 |
chr4_174337071_174337307 | 0.21 |
SCRG1 |
stimulator of chondrogenesis 1 |
16502 |
0.15 |
chr3_43582591_43582742 | 0.21 |
ANO10 |
anoctamin 10 |
14237 |
0.25 |
chr6_152894974_152895125 | 0.21 |
RP11-133I21.2 |
|
27981 |
0.2 |
chr3_149183835_149183986 | 0.21 |
TM4SF4 |
transmembrane 4 L six family member 4 |
7851 |
0.22 |
chr9_4302715_4302866 | 0.21 |
GLIS3 |
GLIS family zinc finger 3 |
2874 |
0.27 |
chr12_27519472_27519623 | 0.21 |
ARNTL2 |
aryl hydrocarbon receptor nuclear translocator-like 2 |
1681 |
0.44 |
chr18_59660622_59660853 | 0.21 |
RNF152 |
ring finger protein 152 |
99273 |
0.08 |
chr2_226986115_226986427 | 0.21 |
ENSG00000263363 |
. |
537238 |
0.0 |
chr15_33210698_33210849 | 0.21 |
FMN1 |
formin 1 |
7688 |
0.22 |
chr7_116804373_116804524 | 0.21 |
ST7-AS2 |
ST7 antisense RNA 2 |
17914 |
0.23 |
chr6_130707481_130707632 | 0.21 |
TMEM200A |
transmembrane protein 200A |
20677 |
0.2 |
chr5_121428399_121428550 | 0.21 |
LOX |
lysyl oxidase |
14494 |
0.2 |
chr12_11864478_11864709 | 0.21 |
ETV6 |
ets variant 6 |
40842 |
0.2 |
chr3_119305313_119305668 | 0.21 |
ADPRH |
ADP-ribosylarginine hydrolase |
4578 |
0.16 |
chr1_97718242_97718393 | 0.20 |
DPYD-AS1 |
DPYD antisense RNA 1 |
156838 |
0.04 |
chr8_59870660_59870811 | 0.20 |
RP11-328K2.1 |
|
34762 |
0.22 |
chr12_109213549_109213779 | 0.20 |
SSH1 |
slingshot protein phosphatase 1 |
6398 |
0.16 |
chr22_46439284_46440015 | 0.20 |
RP6-109B7.5 |
|
9324 |
0.11 |
chr8_25781818_25781969 | 0.20 |
EBF2 |
early B-cell factor 2 |
36461 |
0.23 |
chr3_149165689_149165973 | 0.20 |
TM4SF4 |
transmembrane 4 L six family member 4 |
25930 |
0.17 |
chr5_64337018_64337402 | 0.20 |
ENSG00000207439 |
. |
81986 |
0.11 |
chr8_123197757_123197908 | 0.20 |
ENSG00000238901 |
. |
485698 |
0.01 |
chr5_158428554_158428967 | 0.20 |
CTD-2363C16.2 |
|
15946 |
0.22 |
chr10_114788206_114788458 | 0.20 |
RP11-57H14.2 |
|
76698 |
0.1 |
chr3_90060750_90060901 | 0.20 |
ENSG00000212598 |
. |
18609 |
0.3 |
chr8_78478320_78478688 | 0.20 |
ENSG00000222334 |
. |
279452 |
0.02 |
chr4_139143123_139143274 | 0.20 |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
20305 |
0.25 |
chr4_81172882_81173033 | 0.20 |
FGF5 |
fibroblast growth factor 5 |
14796 |
0.23 |
chr1_150779693_150780543 | 0.20 |
CTSK |
cathepsin K |
208 |
0.91 |
chr20_48345752_48345903 | 0.20 |
ENSG00000264946 |
. |
7341 |
0.19 |
chr12_101692527_101692678 | 0.20 |
UTP20 |
UTP20, small subunit (SSU) processome component, homolog (yeast) |
18715 |
0.19 |
chr11_14280223_14280374 | 0.19 |
RP11-21L19.1 |
|
14939 |
0.24 |
chr5_143416527_143416678 | 0.19 |
ENSG00000239390 |
. |
103842 |
0.07 |
chr16_4001736_4001887 | 0.19 |
RP11-462G12.1 |
|
1366 |
0.4 |
chr11_77034277_77034428 | 0.19 |
PAK1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
25980 |
0.19 |
chr8_119944366_119944655 | 0.19 |
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
19929 |
0.23 |
chr1_244014136_244014917 | 0.19 |
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
145 |
0.97 |
chr3_30273256_30273457 | 0.19 |
ENSG00000199927 |
. |
72671 |
0.11 |
chr2_9106079_9106230 | 0.19 |
ENSG00000238888 |
. |
12870 |
0.25 |
chr1_178244906_178245188 | 0.19 |
RASAL2 |
RAS protein activator like 2 |
65559 |
0.14 |
chr17_76385949_76386473 | 0.19 |
ENSG00000200063 |
. |
9805 |
0.13 |
chr11_32054621_32054772 | 0.19 |
RP1-17K7.2 |
|
8098 |
0.17 |
chr7_134938605_134938973 | 0.19 |
STRA8 |
stimulated by retinoic acid 8 |
22058 |
0.17 |
chr9_79207509_79207915 | 0.19 |
ENSG00000241781 |
. |
20981 |
0.22 |
chr3_112497948_112498099 | 0.19 |
ENSG00000242770 |
. |
23302 |
0.22 |
chr21_44417521_44417672 | 0.19 |
PKNOX1 |
PBX/knotted 1 homeobox 1 |
22845 |
0.15 |
chr5_149530280_149530569 | 0.19 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
4766 |
0.17 |
chr5_172226180_172226429 | 0.19 |
ENSG00000206741 |
. |
19207 |
0.13 |
chr9_2085870_2086021 | 0.19 |
RP11-264I13.2 |
|
39922 |
0.18 |
chr7_81771662_81771813 | 0.19 |
MIR1255B1 |
microRNA 1255b-1 |
133229 |
0.05 |
chr9_16625723_16625874 | 0.19 |
RP11-62F24.1 |
|
124 |
0.98 |
chr9_89213139_89213290 | 0.19 |
ENSG00000222293 |
. |
175171 |
0.03 |
chrX_39949861_39950479 | 0.19 |
BCOR |
BCL6 corepressor |
6486 |
0.33 |
chr6_3472796_3472947 | 0.19 |
SLC22A23 |
solute carrier family 22, member 23 |
15615 |
0.27 |
chr14_38020205_38020356 | 0.19 |
FOXA1 |
forkhead box A1 |
43959 |
0.16 |
chr13_109597565_109597716 | 0.19 |
MYO16 |
myosin XVI |
59123 |
0.16 |
chr14_61611936_61612087 | 0.19 |
PRKCH |
protein kinase C, eta |
42266 |
0.17 |
chr5_64493902_64494516 | 0.19 |
ENSG00000207439 |
. |
75013 |
0.12 |
chr12_102319723_102319998 | 0.19 |
RP11-512N21.3 |
|
1363 |
0.4 |
chr12_20625127_20625278 | 0.19 |
RP11-284H19.1 |
|
102006 |
0.08 |
chr1_240399314_240399591 | 0.19 |
FMN2 |
formin 2 |
9108 |
0.25 |
chr1_22251707_22252306 | 0.19 |
HSPG2 |
heparan sulfate proteoglycan 2 |
11784 |
0.15 |
chr8_59801983_59802134 | 0.19 |
ENSG00000201231 |
. |
74947 |
0.11 |
chr9_113606609_113606760 | 0.19 |
ENSG00000206923 |
. |
58933 |
0.13 |
chr7_134512008_134512159 | 0.19 |
CALD1 |
caldesmon 1 |
16552 |
0.27 |
chr3_29226532_29226683 | 0.19 |
RBMS3 |
RNA binding motif, single stranded interacting protein 3 |
95866 |
0.08 |
chr8_116477187_116477365 | 0.19 |
TRPS1 |
trichorhinophalangeal syndrome I |
27172 |
0.23 |
chr21_40392911_40393288 | 0.19 |
ENSG00000272015 |
. |
126390 |
0.05 |
chr11_87156993_87157144 | 0.19 |
ENSG00000223015 |
. |
160607 |
0.04 |
chr5_88831623_88831774 | 0.19 |
MEF2C-AS1 |
MEF2C antisense RNA 1 |
117074 |
0.07 |
chr18_448002_448153 | 0.19 |
RP11-720L2.2 |
|
23661 |
0.19 |
chr3_81501815_81501966 | 0.19 |
ENSG00000222389 |
. |
56737 |
0.18 |
chr8_21542340_21542522 | 0.19 |
GFRA2 |
GDNF family receptor alpha 2 |
103404 |
0.07 |
chr7_84252921_84253072 | 0.18 |
ENSG00000265050 |
. |
42328 |
0.21 |
chr12_6472663_6473337 | 0.18 |
SCNN1A |
sodium channel, non-voltage-gated 1 alpha subunit |
313 |
0.83 |
chr3_151102482_151102667 | 0.18 |
P2RY12 |
purinergic receptor P2Y, G-protein coupled, 12 |
26 |
0.98 |
chr7_28064670_28064821 | 0.18 |
JAZF1 |
JAZF zinc finger 1 |
4327 |
0.32 |
chr8_130655393_130655686 | 0.18 |
GSDMC |
gasdermin C |
143595 |
0.04 |
chr8_97024655_97024806 | 0.18 |
GDF6 |
growth differentiation factor 6 |
148290 |
0.04 |
chr9_137118247_137118684 | 0.18 |
ENSG00000221676 |
. |
88779 |
0.07 |
chr6_85535174_85535325 | 0.18 |
TBX18 |
T-box 18 |
61012 |
0.16 |
chr2_169385393_169385803 | 0.18 |
ENSG00000265694 |
. |
53855 |
0.12 |
chr15_77518685_77518901 | 0.18 |
PEAK1 |
pseudopodium-enriched atypical kinase 1 |
26080 |
0.24 |
chr12_66441049_66441200 | 0.18 |
ENSG00000251857 |
. |
18877 |
0.2 |
chr11_130348992_130349281 | 0.18 |
ADAMTS15 |
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
30267 |
0.21 |
chr3_73651209_73651360 | 0.18 |
ENSG00000239119 |
. |
8131 |
0.21 |
chr4_74898801_74899032 | 0.18 |
CXCL3 |
chemokine (C-X-C motif) ligand 3 |
5490 |
0.15 |
chr3_135794311_135794474 | 0.18 |
RP11-305O4.3 |
|
12363 |
0.25 |
chr8_49439487_49439638 | 0.18 |
RP11-770E5.1 |
|
24565 |
0.27 |
chr2_69314906_69315057 | 0.18 |
ANTXR1 |
anthrax toxin receptor 1 |
12246 |
0.2 |
chr3_29931035_29931186 | 0.18 |
RBMS3-AS1 |
RBMS3 antisense RNA 1 |
44537 |
0.21 |
chrX_111881069_111881367 | 0.18 |
ENSG00000200436 |
. |
23667 |
0.22 |
chr2_162963271_162963422 | 0.18 |
DPP4 |
dipeptidyl-peptidase 4 |
32294 |
0.15 |
chr15_43797657_43797855 | 0.18 |
TP53BP1 |
tumor protein p53 binding protein 1 |
5056 |
0.16 |
chr4_89491580_89491731 | 0.18 |
ENSG00000252322 |
. |
13468 |
0.16 |
chr18_10377014_10377165 | 0.18 |
ENSG00000239031 |
. |
12908 |
0.27 |
chr6_134084843_134084994 | 0.18 |
RP3-323P13.2 |
|
3828 |
0.35 |
chr4_146728993_146729144 | 0.18 |
RP11-181K12.2 |
|
25202 |
0.2 |
chr14_90389082_90389233 | 0.18 |
EFCAB11 |
EF-hand calcium binding domain 11 |
31710 |
0.18 |
chr10_13981760_13981911 | 0.18 |
FRMD4A |
FERM domain containing 4A |
32534 |
0.19 |
chr12_58924723_58924874 | 0.18 |
RP11-362K2.2 |
Protein LOC100506869 |
13109 |
0.31 |
chr5_67628013_67628218 | 0.18 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
39719 |
0.21 |
chr10_79992002_79992207 | 0.18 |
ENSG00000201393 |
. |
135160 |
0.05 |
chr7_81267105_81267256 | 0.18 |
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor) |
125132 |
0.06 |
chr1_231837911_231838062 | 0.18 |
ENSG00000222986 |
. |
31605 |
0.2 |
chr8_7251752_7252001 | 0.18 |
ZNF705G |
zinc finger protein 705G |
8796 |
0.15 |
chr2_217180969_217181120 | 0.18 |
AC069155.1 |
|
12996 |
0.17 |
chr1_240262420_240262571 | 0.18 |
FMN2 |
formin 2 |
7315 |
0.26 |
chr8_67067455_67067606 | 0.18 |
CRH |
corticotropin releasing hormone |
23430 |
0.21 |
chr2_189834856_189835007 | 0.18 |
COL3A1 |
collagen, type III, alpha 1 |
4115 |
0.26 |
chr12_26784440_26784591 | 0.18 |
RP11-666F17.1 |
|
8213 |
0.3 |
chr3_29329993_29330144 | 0.18 |
RBMS3-AS3 |
RBMS3 antisense RNA 3 |
2149 |
0.36 |
chr7_34025958_34026171 | 0.18 |
BMPER |
BMP binding endothelial regulator |
80919 |
0.11 |
chr6_109992699_109992850 | 0.18 |
AK9 |
adenylate kinase 9 |
8914 |
0.23 |
chr7_75273876_75274027 | 0.18 |
HIP1 |
huntingtin interacting protein 1 |
32790 |
0.16 |
chr12_25876644_25876795 | 0.18 |
ENSG00000222950 |
. |
55784 |
0.14 |
chr9_79075654_79076239 | 0.18 |
GCNT1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
1800 |
0.46 |
chr2_189674111_189674262 | 0.18 |
DIRC1 |
disrupted in renal carcinoma 1 |
19355 |
0.22 |
chr14_52192816_52192967 | 0.18 |
ENSG00000207004 |
. |
2070 |
0.29 |
chr11_3980211_3980997 | 0.18 |
STIM1 |
stromal interaction molecule 1 |
12031 |
0.18 |
chr10_119215065_119215278 | 0.18 |
EMX2OS |
EMX2 opposite strand/antisense RNA |
21513 |
0.22 |
chr17_13268235_13268519 | 0.18 |
ENSG00000266115 |
. |
135268 |
0.05 |
chr7_98705625_98705861 | 0.18 |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
35899 |
0.17 |
chr5_176972744_176973255 | 0.18 |
FAM193B |
family with sequence similarity 193, member B |
6647 |
0.12 |
chr9_15936653_15936804 | 0.18 |
CCDC171 |
coiled-coil domain containing 171 |
158962 |
0.04 |
chr1_211999301_211999452 | 0.17 |
RP11-552D8.1 |
|
3812 |
0.19 |
chr3_141163664_141163815 | 0.17 |
ZBTB38 |
zinc finger and BTB domain containing 38 |
13174 |
0.22 |
chr16_72570911_72571062 | 0.17 |
ENSG00000221286 |
. |
42550 |
0.18 |
chr3_100736189_100736340 | 0.17 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
23905 |
0.23 |
chr12_56917827_56917978 | 0.17 |
RBMS2 |
RNA binding motif, single stranded interacting protein 2 |
2119 |
0.23 |
chr18_39579349_39579630 | 0.17 |
PIK3C3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
25806 |
0.28 |
chr19_15321258_15321624 | 0.17 |
NOTCH3 |
notch 3 |
9649 |
0.16 |
chr3_171704686_171704902 | 0.17 |
FNDC3B |
fibronectin type III domain containing 3B |
52624 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.2 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:2000831 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.1 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.0 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.1 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.0 | GO:0045188 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.0 | 0.1 | GO:0035929 | steroid hormone secretion(GO:0035929) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.0 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.0 | 0.1 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.2 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.2 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.0 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.0 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.0 | GO:0021508 | floor plate formation(GO:0021508) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.0 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.0 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.2 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.3 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.0 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.0 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.0 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.1 | GO:0043302 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.0 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:1903224 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.0 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.0 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.0 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.0 | 0.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.2 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.5 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.0 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0043256 | laminin complex(GO:0043256) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.2 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.0 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.7 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.0 | 0.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.0 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.0 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.0 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.0 | 0.0 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.0 | 0.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 1.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |